Martin brings an exceptional track record of success in leading large, global healthcare diagnostics businesses. He joins
"We are delighted to welcome Juan to the Accelerate team," said
About Accelerate Diagnostics, Inc.
This press release contains words such as "expects," "shall," "will," "believes" and other similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the company's current beliefs, known events and circumstances at the time of publication and, as such, are subject in the future to unforeseen risks and uncertainties that could cause the company's results of operations, performance and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. For a full discussion of the company's risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in Item 1A in the company's Annual Report on Form 10-K, filed with the SEC on February 26, 2015. In addition, the company's forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties or other contingencies.
CONTACT: Media Contact:
Matt Russell Russell Public Communications520.232.9840 email@example.com Investor Contact: Jamien Jones Blueprint Life Science Group415.375.3340 Ext. 103 firstname.lastname@example.org
Source: Accelerate Diagnostics, Inc.
News Provided by Acquire Media